Healthcare affiliate compliance. MHRA, FDA and ASA-aligned.
Pharmaceutical and healthcare brands face some of the strictest affiliate advertising rules in any regulated sector. Rightlander monitors the affiliate sites, comparison pages and influencer content that promote your products, flagging prescription-only claims, inadequate disclosures and price-promotion breaches before they reach a regulator. Along the way, surface the compliant partners driving legitimate demand so you can invest behind them with confidence.
The affiliate channel carries regulatory risk that is hard to see from inside your organisation.
OTC and prescription-adjacent brands increasingly rely on affiliate networks, comparison sites and health influencers to reach consumers. Each of those partners publishes content your compliance team did not approve, referencing products in ways your marketing guidelines do not permit.
MHRA in the UK, FDA in the US and ASA across the board all hold brand owners accountable for how their products are promoted, even when the publisher is a third party. Rightlander scans the pages that carry your brand and flags the ones that carry risk.
- OTC price-promotion rules are stricter than many affiliates realise. Rightlander detects price claims that breach CAP Code and MHRA promotional guidance.
- Prescription-only marketing restrictions forbid direct-to-consumer advertising for POMs in the UK and most of Europe. Rightlander flags affiliate content that crosses that line.
- Influencer disclosures for health and wellness content carry their own ASA requirements. Rightlander captures posts and checks for required disclosure language.
What Rightlander monitors for healthcare brands.
From affiliate landing pages and comparison sites to social influencer posts and paid search, Rightlander covers the channels where healthcare marketing risk is highest.
POM and prescription-only claim detection
Rightlander scans affiliate and comparison site content for references to prescription-only medicines that breach MHRA or FDA direct-to-consumer advertising rules, flagging pages that present POMs as freely available or omit required prescriber references.
- MHRA prescription-only advertising guidelines
- FDA DTC advertising rule alignment
- EU Directive 2001/83/EC awareness
- Timestamped evidence for regulatory response
OTC price-promotion compliance
Price claims on OTC medicines are governed by the CAP Code, MHRA promotional guidance and in some territories by specific price reference rules. Rightlander detects misleading comparative pricing, unauthorised promotional offers and claims that overstate OTC product benefits.
- CAP Code Section 12 (medicines) alignment
- MHRA Blue Guide promotional rules
- Comparative price claim detection
- Benefit and efficacy overclaim flagging
Influencer and social monitoring
Health and wellness influencers operate in a regulatory grey area. Rightlander tracks affiliate and influencer posts on Instagram, TikTok, YouTube and X for inadequate disclosure language, unlicensed product claims and content that presents health outcomes as guaranteed rather than variable.
- ASA #ad and disclosure detection
- Story and reel capture before deletion
- Outcome claim and testimonial flagging
- Influencer-partner attribution tracking
Comparison site and affiliate page scanning
Comparison and review sites are among the most visited sources for OTC product research. Rightlander monitors the pages your affiliates and comparison publishers produce about your products, checking claims against the product characteristics your regulatory team has approved.
- Continuous crawl of partner and comparison pages
- Claim-level flagging with full page context
- Partner notification workflow built in
- Audit-ready evidence on every flag
Healthcare affiliate marketing is governed by rules that most affiliates underestimate and most brands under-monitor.
MHRA promotional guidelines make clear that the holder of the marketing authorisation is responsible for the accuracy and legality of all promotional activity relating to their product, whether that activity is produced by the brand itself or by a third-party affiliate. This means an affiliate comparison site that presents a prescription-only product as freely available without prescriber oversight, or that overstates the efficacy of an OTC remedy, is a compliance liability for the brand whose product it promotes. The MHRA can and does act against brands for affiliate content that breaches the Blue Guide, and has required corrective action in cases where the brand was unaware of the specific page that carried the infringing claim.
The FDA's oversight of direct-to-consumer advertising for prescription drugs and the equivalent provisions of EU Directive 2001/83/EC on medicinal products create parallel obligations for brands operating in North American and European markets simultaneously. The FDA's regulatory letters have referenced third-party promotional content on multiple occasions, confirming that the obligation to monitor extends beyond channels the brand directly controls. EMA guidance on risk-management plans for medicines with significant benefit-risk profiles increasingly references digital channel oversight as a component of post-marketing obligations. For a healthcare brand with affiliates across these jurisdictions, the combination of MHRA, FDA and EMA requirements creates a monitoring obligation that grows with each market the programme enters.
ASA enforcement on health and wellness claims has intensified in recent years, with particular attention to influencer and affiliate content that presents health outcomes as typical rather than variable, or that implies clinical validation that the product does not have. CAP Code Section 12 (medicines, treatments and health) applies to affiliate pages promoting both OTC products and health supplements. Rightlander Compliance monitors partner content against CAP Code Section 12, MHRA promotional standards and FDA DTC rules simultaneously, so a brand active in both markets does not need separate monitoring tools. Social media monitoring extends the same coverage to influencer content on Instagram, TikTok and YouTube.
From scan to resolution in three steps.
Rightlander scans your partner network
We ingest your affiliate and partner list, then continuously scan the pages those partners publish that reference your products. This includes affiliate landing pages, comparison site listings and social content from influencers in your programme. You configure the product names, claims and promotional rules you want monitored. Rightlander applies them across the full scan surface.
Violations are flagged with full evidence
Each flag comes with a timestamped screenshot, the URL of the offending page, the specific claim that triggered the rule and jurisdiction context. Compliance teams can review the evidence directly in the platform without navigating away. The case workbench records every action taken, creating the audit trail a regulator or legal team would ask for.
Partners are notified and cases are closed
Rightlander's built-in workflow routes each flag to the appropriate partner notification. Partners receive a structured takedown or correction request. The platform tracks their response, records remediation and closes the case when the content is corrected or removed. Your compliance record is maintained automatically as cases move through the workflow.
Healthcare compliance questions, answered.
Which healthcare regulators does Rightlander align with?
Rightlander's healthcare monitoring is informed by MHRA promotional guidelines for the UK, FDA direct-to-consumer advertising rules for the US, ASA and CAP Code requirements for advertising standards, and the principles of EU Directive 2001/83/EC on medicinal product advertising. The specific rules applied to your programme are configured during onboarding based on the markets and product categories you operate in.
Can Rightlander distinguish between OTC products and prescription-only medicines?
Yes. During setup, your team provides the product list and classification for the items in your portfolio. Rightlander applies different rule sets to OTC and POM product references accordingly. A page promoting an OTC product with an exaggerated efficacy claim triggers a different category of flag than a page that presents a prescription-only product as directly purchasable without a prescriber reference.
Does Rightlander monitor influencers who promote health products but are not in our formal affiliate programme?
Rightlander's primary coverage is the partners and affiliates in your programme. For influencers operating outside your formal network, we can extend monitoring to specific accounts or domains you provide. Social monitoring captures posts from nominated accounts and, where content uses trackable affiliate links, can associate those posts back to programme participants.
How quickly does Rightlander flag a new piece of non-compliant content?
The scan cycle runs continuously. Pages in your monitored set are checked on a regular cadence, with the frequency configurable based on the risk profile of the partner and the content type. High-priority partners and social channels can be scanned more frequently. Flags appear in the platform workbench as soon as a violation is detected, rather than in a weekly batch report.
What evidence does Rightlander capture for regulatory purposes?
Each flag includes a full-page screenshot taken at the moment of detection, the URL, the date and time of the capture, the specific rule that was triggered and the jurisdiction context. This evidence is stored in the case workbench alongside the notification history and partner responses. If a regulator asks what action you took in response to a specific piece of content, the complete record is available in a structured, exportable format.
We have affiliates in multiple countries. Can Rightlander handle multi-market monitoring?
Yes. Rightlander scans across markets and applies the correct rule context per territory. For healthcare brands, this is particularly relevant because OTC classification, advertising standards and permissible claims differ significantly between the UK, EU member states and the US. The platform applies the appropriate regulatory context based on the market the content is aimed at, not just the location of the affiliate's server.